SCHEMBL859294

SCHEMBL859294

CC(=O)C1(C)CCc2ccccc2N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
MAPK13 O15264 1/20 0.41
MAPK12 P53778 1/20 0.41
MAPK11 Q15759 1/20 0.41
MAPK14 Q16539 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 1/20 0.39
HSD17B3 P37058 1/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP1A2 P05177 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
PTK2B Q14289 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
TP53 P04637 1/20 0.35
ALOX15 P16050 1/20 0.35
HTT P42858 1/20 0.35
MAPK1 P28482 1/20 0.35
GAA P10253 1/20 0.35
BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10098236 0.87 MEN1 (0.43) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL29789709 0.74 MAPT (0.46) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL5331013 0.74 MAPT (0.46) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL6773172 0.72 BRD4 (0.42) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL5837737 0.72 BRD4 (0.42) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL13774368 0.72 NPC1 (0.46) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL6195582 0.71 NPC1 (0.38) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL29746397 0.69 MAPT (0.44) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL26613465 0.69 MAPT (0.44) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL14828715 0.69 PARP1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324217-B2 Cold menthol receptor antagonists JANSSEN PHARMACEUTICA NV (BE) 2012-12-04 US disclosed
US-20120136006-A1 COLD MENTHOL RECEPTOR ANTAGONISTS COLBURN RAYMOND W (US) 2012-05-31 US disclosed
US-8143259-B2 Cold menthol receptor antagonists JANSSEN PHARMACEUTICA, NV (BE) 2012-03-27 US disclosed
US-20100048589-A1 Cold Menthol Receptor Antagonists JANSSEN PHARMACEUTICA NV (BE) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048589-A1 Cold Menthol Receptor Antagonists TRPV1, TRPM2, TRPM6 NPC1 1284/4885MAPK13 3828/4885MAPK12 3386/4885
US-20120136006-A1 COLD MENTHOL RECEPTOR ANTAGONISTS TRPV1, TRPM2, TRPM6 NPC1 1284/4885MAPK13 3828/4885MAPK12 3386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.